Bryn Talkington picks AbbVie as final trade with $232 price target. Bill Baruch chooses Entegris . Oracle and Apple also feature.
Importance Rank:
1
Bryn Talkington picks AbbVie as final trade with $232 price target. Bill Baruch chooses Entegris . Oracle and Apple also feature.